C entral giant cell granuloma (CGCG) is a relatively rare nonneoplastic, intraosseus lesion first described by Jaffe in 1953, and it accounts for less than 7% of all benign maxillofacial bone lesions.1 CGCG occurs more often in the mandible than in the maxilla, affects females more than males, and is commonly seen in individuals under the age of 30. The clinical behavior of CGCG varies and ranges from a slowly growing asymptomatic swelling to a tender aggressive lesion that causes local bone lysis, pain, root resorption, and displacement of teeth.